Medical Research

  • Paxlovid, effective in preventing severe COVID-19, didn’t appear to help long-COVID patients in this single-center study. But further research may show benefits with different doses or for people with specific symptoms.

  • Williams receives $18 million NIH grant

    Professor of psychiatry and behavioral health Leanne Williams will lead a project to define depression’s cognitive biotypes and create tools for clinicians to diagnose and treat patients.

  • Myelination may drive drug addiction

    New research in mice by Stanford Medicine scientists has found that the process of adaptive myelination, which helps the brain learn new skills, can also promote addiction to opioids.

  • Foretelling breast cancer

    In a finding that vastly expands the understanding of tumor evolution, researchers discover genetic biomarkers that can predict the breast cancer subtype a patient is likely to develop.

  • George Hahn dies at 98

    A personal tragedy spurred Hahn, who had escaped Nazi Europe as a child, to pursue a career seeking new therapies for cancer.

  • Speech impairment in Parkinson’s

    Most Parkinson’s disease patients struggle with speech problems. New research by Stanford Medicine scientists uncovers the brain connections that could be essential to preserving speech.

  • Garcia wins 2024 Passano Award

    Garcia was recognized for his research into the way molecules bind to one another and its implications for safer and more effective treatments.

  • A.C. Matin dies at 83

    The microbiologist, on the faculty for nearly half a century, studied a wide range of topics, including antibiotic resistance, cancer, and bacteria as an agent for cleaning up toxic chemicals.

  • Cell-based therapy for solid tumors

    The FDA recently approved the first cell-based therapy — widely used in treating blood cancers — for solid tumors. Stanford Medicine treated the first patient with advanced melanoma.

  • Studying neurodevelopmental disorders

    Stanford Medicine research on Timothy syndrome — which predisposes newborns to autism and epilepsy — may extend well beyond the rare genetic disorder to schizophrenia and other conditions.

  • New epilepsy target

    Researchers find that a little-understood part of the brain appears to be involved in starting seizures and keeping them going.

  • Elizabeth Mellins dies

    Mellins, who studied autoimmune disease and co-founded a large pediatric rheumatology research network, was a tireless mentor and advocate for her field.


Related Websites